MyMD subsidiary Oravax Medical is preparing to commence clinical trials for its oral COVID-19 vaccine, a standalone vaccine and a booster for people who have been previously vaccinated for COVID-19
MyMD subsidiary Oravax Medical is preparing to commence clinical trials for its oral COVID-19 vaccine, a standalone vaccine and a booster for people who have been previously vaccinated for COVID-19